Emergency Department Telephone Quitline
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00394420|
Recruitment Status : Completed
First Posted : November 1, 2006
Last Update Posted : January 20, 2010
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Dependence||Behavioral: Telephone Quitline||Not Applicable|
This pilot study was a prospective, randomized, controlled, un-blinded study using a convenience sample of cigarettes smokers recruited through the ED.
Utilizing a computerized block randomization schedule, subjects were randomized in blocks of four to receive a proactive QL intervention through an established QL or a United States Public Health Service (USPHS) self-help manual. Proactive telephone counseling describes counseling that is initiated by a counselor rather than the subject. Both groups received strong advice to quit from study personnel.
Names and telephone numbers of patients randomized to the QL group were faxed to the QL which then initiated contact with the patient. Multiple contact attempts were made over the following week by telephone. Patients in the QL were instructed to call the QL if they had not been reached in one week. QL counseling involved an initial 45-minute telephone session followed by up to four 10 to 15 minute follow-up sessions around their identified quit date. QL patients not successfully contacted within one week of enrollment were sent a letter inviting them to call as well as information on strategies to help them quit.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Telephone Quitline Intervention for Smoking Cessation Through the Emergency Department|
|Study Start Date :||September 2003|
|Actual Primary Completion Date :||April 2006|
|Actual Study Completion Date :||April 2006|
- The primary outcome was completion of the QL intervention.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00394420
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Nicola E. Schiebel, M.D.||Mayo Clinic|